BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 30535496)

  • 1. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma.
    Luo D; Liu Y; Lin S; Tan L; Du Z; Long M; Zhu Y; Peng X; Zong W; Mackenzie GG; Li H; Ouyang N
    Oncol Rep; 2019 Feb; 41(2):1253-1263. PubMed ID: 30535496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDLIM7 Promotes Tumor Metastasis in Papillary Thyroid Carcinoma via Stabilizing Focal Adhesion Kinase Protein.
    Yang F; Yang M; Liu Y; Zhou C; Chen Y; Wu J; Zhang X; Xiao S
    Thyroid; 2024 May; 34(5):598-610. PubMed ID: 38243825
    [No Abstract]   [Full Text] [Related]  

  • 3. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
    Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
    Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.
    Gao H; Sun X; Wang H; Zheng Y
    Cell Cycle; 2020 May; 19(10):1186-1199. PubMed ID: 32306838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Has_circ_0008274 promotes cell proliferation and invasion involving AMPK/mTOR signaling pathway in papillary thyroid carcinoma.
    Zhou GK; Zhang GY; Yuan ZN; Pei R; Liu DM
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8772-8780. PubMed ID: 30575918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
    Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
    J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.
    He J; Zhou M; Li X; Gu S; Cao Y; Xing T; Chen W; Chu C; Gu F; Zhou J; Jin Y; Ma J; Ma D; Zou Q
    Oncogene; 2020 Mar; 39(13):2658-2675. PubMed ID: 32005974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4.
    Qi Y; He J; Zhang Y; Wang L; Yu Y; Yao B; Tian Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropilin-2 promotes growth and progression of papillary thyroid cancer cells.
    Lee G; Kang YE; Oh C; Liu L; Jin Y; Lim MA; Won HR; Chang JW; Koo BS
    Auris Nasus Larynx; 2020 Oct; 47(5):870-880. PubMed ID: 32381353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.
    Yu ST; Zhong Q; Chen RH; Han P; Li SB; Zhang H; Yuan L; Xia TL; Zeng MS; Huang XM
    Cell Death Dis; 2018 Mar; 9(3):371. PubMed ID: 29515111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Lin28A/let-7a/c-Myc Pathway in Growth and Malignant Behavior of Papillary Thyroid Carcinoma.
    Huang J; Lin H; Zhong M; Huang J; Sun S; Lin L; Chen Y
    Med Sci Monit; 2018 Dec; 24():8899-8909. PubMed ID: 30531691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.
    Zheng C; Quan RD; Wu CY; Hu J; Lin BY; Dong XB; Xia EJ; Bhandari A; Zhang XH; Wang OC
    J Cell Mol Med; 2019 Dec; 23(12):7974-7984. PubMed ID: 31568662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting
    Yu C; Zhang L; Luo D; Yan F; Liu J; Shao S; Zhao L; Jin T; Zhao J; Gao L
    Thyroid; 2018 Dec; 28(12):1627-1641. PubMed ID: 30244634
    [No Abstract]   [Full Text] [Related]  

  • 14. BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability.
    Zhao M; Yang F; Sang C; Yan C; Wang Z
    J Endocrinol Invest; 2021 Oct; 44(10):2165-2174. PubMed ID: 33543443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TFE3 Regulates the Function of the Autophagy-Lysosome Pathway to Drive the Invasion and Metastasis of Papillary Thyroid Carcinoma.
    Lu H; Zhu C; Ruan Y; Fan L; Wei K; Yang Z; Chen Q
    Anal Cell Pathol (Amst); 2021; 2021():3081491. PubMed ID: 34660181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression.
    Cai X; Zhao Z; Dong J; Lv Q; Yun B; Liu J; Shen Y; Kang J; Li J
    Cell Death Dis; 2019 Feb; 10(3):184. PubMed ID: 30796202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1.
    Han J; Zhang M; Nie C; Jia J; Wang F; Yu J; Bi W; Liu B; Sheng R; He G; Kong L; Zheng L; Pang R; Ding Z; Chen L; Guan Q; Pan S; Meng X; Xu J; Liu L; Zhang J
    Cell Death Dis; 2019 Feb; 10(3):195. PubMed ID: 30814512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma.
    Deng XY; Gan XX; Feng JH; Cai WS; Wang XQ; Shen L; Luo HT; Chen Z; Guo M; Cao J; Shen F; Xu B
    Cell Biochem Funct; 2021 Mar; 39(2):317-325. PubMed ID: 32881051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHCBP1 Promotes Papillary Thyroid Carcinoma Carcinogenesis and Progression Through Promoting Formation of Integrin and Collagen and Maintaining Cell Stemness.
    Geng H; Guo M; Xu W; Zang X; Wu T; Teng F; Wang Y; Liu X; Wang X; Sun Q; Liang J
    Front Endocrinol (Lausanne); 2020; 11():613879. PubMed ID: 33716952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the ROCK1/MMP-9 pathway is associated with the invasion and poor prognosis in papillary thyroid carcinoma.
    Luo D; Chen H; Li X; Lu P; Long M; Peng X; Lin S; Tan L; Zhu Y; Ouyang N; Li H
    Int J Oncol; 2017 Oct; 51(4):1209-1218. PubMed ID: 28848996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.